EUDA Health Collaborates With GO POSB Organoids And Shenzhen Innovation To Develop Next‑Gen Off‑the‑Shelf iPSC‑Based NK Cell Therapies For Wellness And Oncology Across Asia
EUDA Health Holdings Limited (NASDAQ:EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today
EUDA Health is teaming up with other companies to create new cell-based medicines that might help fight cancer and boost wellness across Asia. When companies announce big research partnerships, it shows they're investing in future products—watch to see if this eventually leads to real medicines people can actually use.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.